Dr. Ramnath Shenoy K

Qualifications:
MBBS, DNB(Paed), DM(Oncology)Tata memorial hospital, Mumbai Consultant Medical Oncologist

Areas of Interest:

• Haematolymphoid and solid Malignancies

Professional Strenghts

• Experience in Managing all Adult and paediatric solid and Hematological Malignancies.
• Worked in Bone Marrow Transplant unit for 6 months in ACTREC, Kharghar.

Scientific presentations

• Clinical Profile and Outcome of HER2 Positive Breast Cancer Patients With Brain Metastases Treated With HER2 Targeted Therapy: ESMO 2019 Conferece, Barcelona, Spain
• Efficacy of Artesunate for treatement of Cytomegalovirus Reactivations in Allogenic Hematopoietic Srem cell Transplant Recipients Who Are Intolerant/Unsuitable for Ganciclovir Therapy In American Society of Hematology (ASH) Conference 2019, Florida, USA (Received ASH Abstract Achieved Award)

Publications

• A child with bulky kidneys and renal failure. In: Indian Journal of Medical and Pediatric Oncology. 2018; Vol. 39, No. 3. pp. 388-390.
• “Targeting NTRK fusions in Cancers” a chapter in evidence-based Management of cancers in India -2021
• Shenoy, R., Panda, G., Bonda, V.N.A. et al. Feasibility of Delivering High-Dose Methotrexate in Adolescent and Adult All Patients: A Retrospective Study. Indian J Hematol Blood Transfus (2021).
• Low-cost oral metronomic chemotherapy versus intravenous cisplatin in patients with recurrent, metastatic, inoperable head and neck carcinoma: an open-label, parallel-group, non-inferiority, randomized, phase 3 trial-Lancet Global Health- Volume 8, issue 9, e1213-e1222, September 01, 2020